Lymphoma of Mucosa-associated Lymphoid Tissue

• CLINICAL_TRIALS trial_result · 2021-05-07
  Clinical Trial Update: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Phase 2]

  Phase 2 trial evaluating lenalidomide with low-dose dexamethasone and rituximab in rituximab-resistant, non-aggressive B-cell lymphomas; com…

• CLINICAL_TRIALS trial_result · 2013-12-24
  Clinical Trial Update: Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma [Phase 2]

  A Phase 2 trial evaluating rituximab plus cladribine (2-CdA) in advanced or relapsed mucosa-associated lymphoid tissue lymphoma has complete…